EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

OncoTargets and Therapy

ISSN 1178-6930 · Informa UK Limited

Latest articles

  1. Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) – A Trial in Progress

    Jasson Villarreal Hernandez, Javier Octavio Díaz Carbonero, Chiara Paoli, Paola Guglielmelli, Mario Tiribelli, Francesca Palandri, Jesus Maria Hernandez-Rivas, María Laura Fox, Damián Cubillas García de la Torre, Graeme Greenfield, Ciro Rinaldi, Priya Sriskandarajah, Claire Harrison, Fabrizio Pane, Giuseppe Lanzarone, Daniela Cilloni, Matteo Pacilli, Massimo Breccia, Michael Lahn, Giusy Di Conza, Tracey C Hammett, Paramjit Kaur, Michael Emig, Karen M Tonge, Mireille Cantarini, Johanne Polasek, Alessandro Lucchesi, Armando Santoro, Alessandro Maria Vannucchi

    Published: 2026-10DOI: 10.2147/ott.s631781

Volumes

2026 · 1162025 · 1042024 · 1422023 · 1462022 · 1912021 · 5322020 · 1,1732019 · 1,0292018 · 9012017 · 6142016 · 8032015 · 4522014 · 2572013 · 2182012 · 542011 · 182010 · 232009 · 242008 · 11

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.